Is a type of immunotherapy used in cancer treatment. The therapy involves the isolation of white blood cells, such as lymphocytes, from a patient's blood, which are then exposed to interleukin-2 (IL-2) in a laboratory setting to activate them. The activated cells are then infused back into the patient's body, where they can recognize and attack cancer cells.